Activity Overview Intended Audience: Hepatologists, gastroenterologists, primary care physicians, endocrinologists (including diabetologists), and their clinical teams (NPs, PAs, nurses, and pharmacists) caring for patients with MASH Therapeutic strategies that address both metabolic dysfunction-associated steatohepatitis (MASH) and its underlying metabolic drivers are increasingly important given it frequent coexistence with conditions such as obesity, type 2 diabetes, and dyslipidemia
Despite the susceptibility of C-terminal cleavage, using albumin for half-life extension of biologics remains appealing for several reasons
300-01A, PeproTech) for 4 h in the presence or absence of 1 g ml 1 anti-ICAM-1, anti-VCAM-1 or anti-PECAM-1 antibodies before incubation with 1 10 5 MitoTracker Orange-labeled PBMCs (cat
The maturation of dendritic cells (DCs) in the TDLNs and tumors of mice upon various treatments was first analyzed using flow cytometry